Literature DB >> 27402071

Hydroxychloroquine-induced retinopathy in a 57-year-old woman.

Alex Ragan1, Michael Fielden2.   

Abstract

Entities:  

Year:  2016        PMID： 27402071      PMCID： PMC5235928          DOI： 10.1503/cmaj.150716

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Frederick Wolfe; Michael F Marmor
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

2.  Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine.

Authors:  R Bergholz; J Schroeter; K Rüther
Journal:  Br J Ophthalmol       Date:  2010-10-12       Impact factor: 4.638

Review 3.  Antimalarial drugs in the treatment of rheumatological diseases.

Authors:  R I Rynes
Journal:  Br J Rheumatol       Date:  1997-07

4.  Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.

Authors:  Michel Michaelides; Niamh B Stover; Peter J Francis; Richard G Weleber
Journal:  Arch Ophthalmol       Date:  2011-01

Review 5.  Ocular toxicity of hydroxychloroquine.

Authors:  J C S Yam; A K H Kwok
Journal:  Hong Kong Med J       Date:  2006-08       Impact factor: 2.227

6.  The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.

Authors:  Ronald B Melles; Michael F Marmor
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

7.  Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.

Authors:  Mihai Mititelu; Brandon J Wong; Marie Brenner; Paul J Bryar; Lee M Jampol; Amani A Fawzi
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

8.  Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Jonathan S Lyons; William F Mieler
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

9.  The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.

Authors:  Ioannis Mavrikakis; Petros P Sfikakis; Emmanouil Mavrikakis; Kostantinos Rougas; Athanasios Nikolaou; Charalambos Kostopoulos; Myron Mavrikakis
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

10.  Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment.

Authors:  R I Rynes
Journal:  Am J Med       Date:  1983-07-18       Impact factor: 4.965
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.